Borad MJ, Bai LY, Richards D, Mody K, et al. Silmitasertib Plus Gemcitabine and Cisplatin First-Line Therapy in Locally Advanced/Metastatic Cholangiocarcinoma: a Phase 1b/2 Study. Hepatology 2022 Sep 24. doi: 10.1002/hep.32804.
PMID: 36152015